Facing global challenges such as ageing population and uneven distribution of healthcare resources, Taiwan-based startup Acer Medical continues to drive clinical adoption of AI-powered solutions. Recently, Acer Medical partnered with Upsynergy Taiwan and Thailand-based New Eye Inc., a long-established leader in ophthalmic equipment, to build an integrated healthcare ecosystem in Thailand.
This collaboration combines advanced ophthalmic devices, AI-assisted diagnostic systems (VeriSee), and telemedicine services, injecting new momentum into Thailand's healthcare system and shaping a cross-border smart healthcare ecosystem.
Acer Medical is actively expanding its presence in Thailand. Its AI-driven ophthalmology solutions—spanning both software and hardware—have already obtained regulatory approval from the Thailand Food and Drug Administration (TFDA), marking a key milestone for market entry.
Through strategic collaborations with New Eye and Upsynergy Taiwan, Acer Medical has achieved tangible progress in the Thai market:
This collaboration marks another important milestone in Taiwan–Thailand smart healthcare cooperation. Acer Medical will continue to work closely with global partners, leveraging a strategy that integrates technology, local partnerships, and clinical implementation to accelerate the long-term development of AI healthcare worldwide and lead the wave of digital transformation in Southeast Asia.
